Next-generation Sequencing Library Preparation

Global Next-generation Sequencing Library Preparation Market to Reach US$4.1 Billion by 2030

The global market for Next-generation Sequencing Library Preparation estimated at US$1.9 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. Targeted Genome Sequencing, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Whole Genome Sequencing segment is estimated at 15.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$503.5 Million While China is Forecast to Grow at 12.8% CAGR

The Next-generation Sequencing Library Preparation market in the U.S. is estimated at US$503.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$638.2 Million by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.9% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.

Global Next-Generation Sequencing Library Preparation Market – Key Trends & Drivers Summarized

How Is Next-Generation Sequencing Library Preparation Advancing Genomic Research?

Next-generation sequencing (NGS) library preparation is a critical step in genomic analysis, enabling researchers to convert DNA and RNA samples into formats suitable for high-throughput sequencing. The preparation process involves fragmentation, adapter ligation, amplification, and quality control, ensuring accurate and efficient sequencing. NGS technology has revolutionized genetics, allowing for faster and more cost-effective analysis of genomes, transcriptomes, and epigenomes across various applications, including precision medicine, oncology, infectious disease research, and agricultural genomics. The increasing adoption of NGS in clinical diagnostics is driving demand for more streamlined, automation-friendly, and scalable library preparation kits that enhance efficiency and reproducibility. Additionally, advancements in single-cell sequencing and long-read sequencing are pushing the boundaries of genome analysis, necessitating improved library preparation methods tailored for complex samples. As researchers strive for higher sequencing accuracy, sensitivity, and throughput, library preparation technologies continue to evolve, playing a crucial role in advancing the field of genomics.

What Challenges Are Affecting the Adoption of NGS Library Preparation Technologies?

Despite its transformative potential, the NGS library preparation market faces several challenges that impact accessibility, efficiency, and cost-effectiveness. One of the primary concerns is the labor-intensive nature of traditional library preparation methods, which require skilled technicians, expensive reagents, and extensive sample handling. Variability in sample quality and preparation efficiency can lead to sequencing errors and reduced data reliability, necessitating robust quality control measures. Another major challenge is the high cost of library preparation kits, which can be prohibitive for smaller research institutions and clinical laboratories. Additionally, the complexity of handling diverse sample types, including low-input and degraded DNA, requires highly specialized protocols, increasing the need for customized solutions. Regulatory challenges and standardization issues further hinder clinical adoption, as laboratories must adhere to stringent compliance requirements for NGS-based diagnostics. Overcoming these challenges will require continued innovation in automation, reagent chemistry, and bioinformatics solutions to make NGS library preparation more efficient, cost-effective, and scalable for a wider range of applications.

How Are Innovations Driving the Future of NGS Library Preparation?

Technological advancements are significantly improving the efficiency and accuracy of NGS library preparation, addressing key challenges in sample processing and sequencing quality. One of the most impactful innovations is the automation of library preparation workflows, reducing hands-on time, minimizing human error, and increasing sample throughput. Robotic liquid handling systems and microfluidic platforms are streamlining the preparation process, making high-throughput sequencing more accessible to clinical and research laboratories. The development of transposase-based library preparation methods, such as Illumina’s Nextera technology, is simplifying DNA fragmentation and adapter insertion, reducing preparation time and reagent costs. Additionally, single-tube and direct RNA sequencing approaches are eliminating the need for complex workflows, improving efficiency in transcriptomics studies. Advances in molecular barcoding and unique molecular identifiers (UMIs) are enhancing sequencing accuracy by reducing PCR bias and detecting low-frequency variants. The integration of AI and machine learning in bioinformatics is also optimizing library preparation protocols by predicting optimal reagent conditions and improving data interpretation. As these innovations continue to evolve, the NGS library preparation market is poised for greater efficiency, scalability, and clinical adoption.

What Is Driving the Growth of the NGS Library Preparation Market?

The growth in the next-generation sequencing library preparation market is driven by several factors, including increasing demand for personalized medicine, expanding applications of NGS in disease research, and technological advancements in automation and reagent chemistry. The growing adoption of NGS-based diagnostics in oncology, infectious diseases, and rare genetic disorders is fueling demand for more efficient and cost-effective library preparation solutions. The rise of single-cell sequencing is also contributing to market growth, as researchers require specialized library preparation methods to analyze individual cells with high sensitivity. Additionally, the expansion of agricultural genomics, microbiome studies, and synthetic biology is further driving market demand, as these fields rely on high-throughput sequencing for genomic analysis. The push for standardization and regulatory approvals for clinical NGS applications is also shaping market trends, with manufacturers developing compliant library preparation kits that meet stringent diagnostic requirements. Investments in bioinformatics and cloud-based sequencing platforms are enhancing data management and accessibility, making NGS more widely available for diverse research and clinical applications. As advancements in sequencing technologies continue to lower costs and improve accuracy, the NGS library preparation market is expected to witness sustained growth, revolutionizing genomic research and precision medicine.

SCOPE OF STUDY:

The report analyzes the Next-generation Sequencing Library Preparation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Other Sequencing Types); Product Type (Library Preparation Reagents & Consumables, Library Preparation Instruments); Application (Drug & Biomarker Discovery Application, Disease Diagnostics Application, Cancer Diagnostics Application, Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications); End-Use (Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -
  • Agilent Technologies, Inc.
  • Alida Biosciences, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • Claret Bioscience LLC
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • Hamilton Company
  • Illumina, Inc.
  • New England Biolabs Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Swift Biosciences Inc.
  • Takara Bio Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Next-generation Sequencing Library Preparation – Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Surge in Precision Medicine Initiatives Throws the Spotlight on Customized NGS Library Preparation Solutions
Rapid Growth of Clinical Diagnostics Strengthens Business Case for Automation in Library Preparation Workflows
Increasing Focus on Genomic Surveillance Accelerates Demand for High-Throughput NGS Library Prep Kits
Rising Investments in Cancer Genomics Propels Growth of Targeted Sequencing Library Preparation Products
Expansion of Population Genomics Programs Expands Addressable Market Opportunity for Large-Scale Library Prep Platforms
Adoption of AI and Machine Learning in Genomic Data Analysis Spurs Demand for Standardized, High-Quality Library Prep Methods
Growing Use of Liquid Biopsy Technologies Drives Adoption of Ultra-Sensitive Library Preparation Protocols
Regulatory Push for Validated and Reproducible Clinical Assays Strengthens Business Case for Commercial NGS Library Kits
Integration of Automation and Robotics in Lab Workflows Drives Efficiency and Reduces Human Error in Library Preparation
Increasing Demand for Decentralized Testing Models Spurs Development of Point-of-Care Compatible Library Prep Technologies
Rising Demand for Epigenetic and Transcriptomic Studies Expands Scope for Specialized Library Preparation Solutions
Advancements in Long-Read Sequencing Technologies Drives Innovation in Compatible Library Preparation Reagents
Continuous Decline in Sequencing Costs Sustains Growth Momentum Across Research and Clinical Applications
Strategic Collaborations Between Pharma and Genomics Firms Fuel Adoption of Scalable NGS Library Preparation Platforms
Expansion of Biobanking and Genomic Data Repositories Generates Long-Term Demand for Reliable Library Prep Protocols
Transition to Cloud-Based Genomics Workflows Spurs Demand for Seamlessly Integratable Library Prep Solutions
Emphasis on Quality Control and Standardization Across Labs Strengthens Need for Pre-Validated Library Prep Kits
Accelerating Adoption of NGS in Agriculture and Microbiome Research Opens New Market Avenues for Library Preparation Products
Government Funding Initiatives and Genomics-Focused National Programs Drive Regional Market Penetration and Adoption
Intensifying Competitive Landscape Spurs Innovation in Fast, Cost-Effective, and Scalable Library Preparation Technologies
Emergence of Single-Cell Sequencing Drives Demand for Ultra-Low Input and Specialized Library Prep Workflows
Growing Importance of Data Privacy and Compliance Creates Challenges in Adoption of Cloud-Linked NGS Prep Systems
Movement Toward Personalized Wellness and Preventive Healthcare Expands Market Opportunity for Consumer-Directed Library Prep Solutions
Increasing Academia-Industry Collaborations Propels Development of Customizable and Niche Library Preparation Technologies
Shift Toward Multiplexed and Multi-Omic Sequencing Accelerates Innovation in Versatile Library Prep Protocols
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Next-generation Sequencing Library Preparation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Next-generation Sequencing Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Targeted Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for Targeted Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Other Sequencing Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 11: World 6-Year Perspective for Other Sequencing Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Reproductive Health Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 13: World 6-Year Perspective for Reproductive Health Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 15: World 6-Year Perspective for Infectious Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Other Disease Diagnostic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 17: World 6-Year Perspective for Other Disease Diagnostic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for Drug & Biomarker Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 19: World 6-Year Perspective for Drug & Biomarker Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 21: World 6-Year Perspective for Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Cancer Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 23: World 6-Year Perspective for Cancer Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 24: World Recent Past, Current & Future Analysis for Academic & Research Institutions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 25: World 6-Year Perspective for Academic & Research Institutions End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 27: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 29: World 6-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 30: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 31: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Library Preparation Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 33: World 6-Year Perspective for Library Preparation Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Library Preparation Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 35: World 6-Year Perspective for Library Preparation Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 36: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 37: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
TABLE 40: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 41: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 42: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 43: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
CANADA
TABLE 44: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 45: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
TABLE 46: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 47: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
TABLE 48: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 49: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
JAPAN
Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 52: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 53: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
TABLE 54: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 55: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 58: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 59: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
CHINA
Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 60: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 61: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
TABLE 64: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 65: China 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 66: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 67: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
EUROPE
Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 68: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 69: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
TABLE 70: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 71: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
TABLE 72: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 73: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 76: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 77: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
FRANCE
Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 78: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 79: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
TABLE 80: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
TABLE 82: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 83: France 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 84: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 85: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
GERMANY
Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 86: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
TABLE 88: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 89: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
TABLE 90: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 91: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 92: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
ITALY
TABLE 94: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 95: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
TABLE 96: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 97: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
TABLE 98: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 99: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 100: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 101: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
UNITED KINGDOM
Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 102: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 103: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
TABLE 104: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
TABLE 106: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 107: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 108: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 109: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
REST OF EUROPE
TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 111: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 113: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 115: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 117: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
ASIA-PACIFIC
Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 119: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 121: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 123: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 125: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
REST OF WORLD
TABLE 126: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 127: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
TABLE 128: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 129: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
TABLE 130: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 131: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 132: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 133: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings